Daily Wrap on MSN7h
Russian armoured vehicles vanish from Ukrainian frontlinesBMD-4, and BTR-82 are becoming rare on the front lines in Ukraine, reports the Ukrainian agency UNIAN. Russian armoured ...
Complexity of Serpiginous Right Atrium Thrombus Management in Acute Pulmonary Embolism Patient: A Clinical Case Report. World ...
Global automakers have been reassessing their original plans to transition completely to EVs as growth slows. In the US, EV ...
This study provides compelling evidence that kinesin's stepping mechanism is governed by strain-induced conformational changes in its nucleotide-binding pockets. Using pre-steady state kinetics and ...
The Ministry of Defense has codified and authorized for use in the units of the Ukrainian Defense Forces a number of devices ...
With a crew of four—commander, driver, gunner, and loader—and a 36-round ammunition reserve, the ZTD-05 balances firepower, ...
The aim of our study was to compare the efficacy of 100 mg rectal indomethacin versus diclofenac on PEP incidences. Design This multicentre, double-blinded, randomised controlled trial was conducted ...
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Phase III study showed sustained proteinuria reduction at one yea ...
MG Motor India will soon launch a couple of new cars in the Indian market, and here we talk about them all. The list includes ...
SAIC-owned MG Motor has taken to Weibo to reveal the next-generation MG4 EV, which it says will be the first global model for ...
Developed by Sanofi, CABLIVI is the first FDA-approved nanobody therapy for this condition. Increasing awareness, improved diagnostic rates, and rising demand for targeted therapies in hematology ...
DelveInsight's "CABLIVI Market Size, Forecast, and Market Insight Report" highlights the details around CABLIVI, a von Willebrand factor (vWF)-directed antibody fragment. The report provides product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results